Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Elicera Therapeutics AB
F:8E8
Elicera Therapeutics AB
F:8E8
Price:
0.2335
EUR
-2.91%
Market Closed
Market Cap:
€8.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
Omega Pacific Resources Inc
F:Q0F
|
CA |
|
AECOM
NYSE:ACM
|
US |
|
Sol Gel Technologies Ltd
F:4SG
|
IL |
|
T
|
Tisdale Clean Energy Corp
OTC:TCEFF
|
CA |
|
Maven Brands Inc
F:TLA
|
CA |
|
Bank OCBC NISP Tbk PT
IDX:NISP
|
ID |
|
Sulzer AG
SIX:SUN
|
CH |
Wall St Price Targets
Price Forecast
Based on 4 analysts
Based on 4 analysts
+147% Upside
from
€0.2335
today
Elicera Therapeutics AB (8E8)’s 12-month stock price forecast through October 2027 has a consensus target of €0.5775, implying 147% upside. The forecast is based on price targets from 4 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Elicera Therapeutics AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Elicera Therapeutics AB's stock price target?
Price Target
0.5775
EUR
0.5775
EUR
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 0.5775 EUR with a low forecast of 0.5127 EUR and a high forecast of 0.656 EUR.
What is the Revenue forecast for Elicera Therapeutics AB?
Projected CAGR
96%
96%
Over the last 4 years, the compound annual growth rate for Revenue has been 1 060%. The projected CAGR for the next 3 years is 96%.